CSF3 and breast cancer: Herein, we conducted a study with three proportions of phase 1b trial, phase 2b trial, and phase 2 trial, to evaluate the safety, pharmacokinetics (PK), efficacy, and pharmacodynamics (PD) of rHSA/G-CSF in breast cancer patients receiving anthracycline-containing chemotherapy.